“2014 NUMERIC’ ALSACE Grand Prize” awarded to Visible Patient, an IRCAD spin-off

On November 5, VISIBLE PATIENT, a company which stemmed from 15 years of IRCAD R&D, received the 2014 Numeric’Alsace Grand Prize in Strasbourg. This prize rewards Alsace’s best digital ideas, strategies, solutions and applications. Visible Patient was created in July 2013, and proposes a new type of surgery guided by 3D virtual imaging for every patient, used before and during the intervention.

This prize rewards IRCAD research quality and the ability to turn this research into quality patient care by using Visible Patient.

Visible Patient consists in extracting a Digital 3D clone of the patient, based on real medical imaging (CT-scan or MRI). It is like a virtual copy of the patient. The operator can then plan or simulate the surgical intervention with no risk for the patient.

All Visible Patient software is free and can be used on a computer or a tablet, which reduces costs and allows to train doctors and future physicians with no additional costs. Another benefit of 3D imaging is that it can be used to explain a pathology to the patient along with its treatment modality in a simpler way.

The jury of the contest was put together by the Chamber of Commerce and Industry of the Alsace region. It awarded the prize to Visible Patient due to its innovative features, and its impact on local activity.

The objective of the contest is three-fold:
– To encourage companies to use digital devices;
– To encourage the economic activity of local web service providers;
– To position the Alsace region as a dynamic area in terms of digital tool use.

The young Visible Patient company, which is located within the Haras biocluster, now has 18 employees and plans to recruit over 60 people in Alsace over the next 5 years.

Stay in touch

Don’t miss the latest news from IRCAD.
Sign up here for our newsletters and communication mailings
to stay informed about us and our courses

IRCAD Contact form

COVID19: IRCAD sanitary measures & health pass

Please note that the IRCAD administrative board and staff are closely monitoring the evolving COVID-19 situation, in full compliance with all applicable laws and regulations in France. The health, safety, and well-being of our participants, experts and staff are our top priority!
Despite the current context, the IRCAD stands firmly by your side to help you acquire knowledge and skills. Come and join us !

We would like to draw your attention that the « Vaccine Pass » is now mandatory in France since end of January 2022 and replaces the former « Health Pass » to access places that are open to the public, such as cinemas, museums, cafés and restaurants, hotels as well as the IRCAD Institute which welcomes participants in the framework of its courses and seminars. Thus, a PCR test without vaccination is no longer sufficient to take part in our courses.

The vaccine pass includes a proof of the following (one of the 3 items is sufficient):

  • The vaccination certificate, proving that persons have a complete vaccination (as of January 15, 2022, all persons aged 18 and over must receive a booster dose no more than 7 months after their last injection or Covid infection to receive a valid vaccination pass. As of February 15, 2022, the time limits for keeping the pass will be reduced, you will have to do your booster dose 4 months and no longer 7 months after your 2nd dose to have a complete vaccine schedule and maintain a valid vaccine pass)
  • The result of a positive RT-PCR or antigenic test attesting to the recovery of Covid, more than 11 days and less than 4 months
  • The certificate of contraindication to vaccination

Further information about the new vaccine pass can be found at :

We very much hope to be able to count on your kind understanding of those rules which have been set by the French Government and which our Institute is required to apply

Registration form to Medtronic's educational program